| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225447 Methods for producing members of specific binding pairs |
| 05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
| 05/01/2001 | US6224848 Pharmaceuticals providing diagnosis and selective tissue necrosis using Mossbauer absorber atom |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/25/2001 | EP1093522A2 Proteases fused with variants of stretptomyces subtilisin inhibitor |
| 04/25/2001 | EP1093516A2 Mammalian genes; dendritic cell prostaglandin-like transporter (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/25/2001 | EP1093464A2 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/24/2001 | US6222094 Mammal whose germ and mammary gland cells contain dna coding for peptide of defined amino acid sequence, signal sequence for secretion, and functional promoter; recombinant production of infant formula |
| 04/24/2001 | US6221958 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221355 Anti-pathogen system and methods of use thereof |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/19/2001 | WO2001027293A1 Purification of recombinant proteins fused to multiple epitopes |
| 04/19/2001 | WO2001027292A2 Methods and compositions for targeting a cell |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027159A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001026608A2 Dna vaccines encoding antigen linked to a domain that binds cd40 |
| 04/19/2001 | WO2001019846A8 Transgenically produced fusion proteins |
| 04/19/2001 | WO2001002565A3 Secreted protein zacrp4 |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2386824A1 Methods and compositions for targeting a cell |
| 04/18/2001 | EP1092771A2 Tetracycline-regulated transcriptional modulators |
| 04/18/2001 | EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 04/18/2001 | EP1091971A2 Polyketides and their synthesis |
| 04/18/2001 | EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291995A Enhancing circulating half-life of antibody-based fusion proteins |
| 04/17/2001 | US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities |
| 04/17/2001 | US6218160 Site-specific conjugation of glycoproteins |
| 04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | WO2001025401A2 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025282A1 Il13 mutants |
| 04/12/2001 | WO2001025278A1 C-peptide for the improved production of insulin and insulin analogues |
| 04/12/2001 | WO2001024820A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | WO2001024811A1 April receptor (bcma) and uses thereof |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000018881A8 Intein mediated peptide ligation |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | CA2386854A1 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins |
| 04/12/2001 | CA2386841A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | CA2386248A1 Il13 mutants |
| 04/11/2001 | EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
| 04/11/2001 | EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells |
| 04/11/2001 | EP1090123A2 Polyketides and their synthesis |
| 04/11/2001 | EP1090039A1 Peptide composition as immunogen for the treatment of allergy |
| 04/11/2001 | EP0517829B1 Improved chimeric toxins |
| 04/11/2001 | CN1291199A Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/10/2001 | US6214606 Non-chromosomal dna which encodes the protein of defined amino acid sequence; for folding newly synthesized proteins into their biologically active conformation |
| 04/10/2001 | US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| 04/10/2001 | US6214347 Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1 |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/05/2001 | WO2001023552A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | WO2001023543A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | WO2001023422A1 Vaccine |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2000061617A3 Transiently immortalized cells for use in gene therapy |
| 04/05/2001 | DE19947456A1 New synthetic derivatives of the C-peptide of proinsulin, useful in the preparation of human insulin or insulin analogs in high yield |
| 04/05/2001 | CA2386032A1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | CA2385633A1 Paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | CA2385609A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | CA2384723A1 Vaccine |
| 04/04/2001 | EP1088888A1 Fused protein |
| 04/04/2001 | EP1088084A2 Erythropoietin analog-human serum albumin fusion protein |
| 04/04/2001 | EP1088083A1 Expression vector for use in a one-step purification protocol |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | EP1087784A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 04/04/2001 | EP0939767A4 Modified factor viii |
| 04/04/2001 | CN1290301A Single-chain bifunctional glycoprotein hormones |
| 04/03/2001 | US6211427 Peptide production as fusion protein in transgenic mammal milk |
| 04/03/2001 | US6210962 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof |
| 04/03/2001 | US6210929 Fusion protein of furin with catalytic center and c-terminal deletion, flexible peptide spacer, and histidine-tag affinity peptide; for proteolytic processing/activation of recombinant proteins |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | CA2183371C Pna combinatorial libraries and improved methods of synthesis |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021656A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 03/29/2001 | WO2001021215A1 Cell based assay |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021193A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | WO2000032823A9 Dna-protein fusions and uses thereof |
| 03/29/2001 | WO2000020607A9 Chimaeric proteins between members of tgf-beta superfamily |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | CA2793128A1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 03/29/2001 | CA2383629A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | CA2383591A1 Cell based assay |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |